Remarkably, our observation on an association of the lower CTLA-4 expression on CD4 T cells with shortened TTP in NDMM patients confirms the suggestion that blocking CTLA-4 in MM may be an unfavorable therapeutic strategy for a proportion of MM patients, primarily at diagnosis. The gene discussed is CD4; the disease is Miyoshi myopathy.